+674.0%
MRNA vs BRKR
+72.0%
+602.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BRKR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.2% | +5.6% | +5.5% |
| 7D | -1.1% | -8.7% | +7.6% | +2.5% |
| 30D | +126.1% | -9.9% | +136.0% | +135.4% |
| 3M | +190.0% | -3.1% | +193.1% | +187.9% |
| 6M | +157.2% | +45.5% | +111.7% | +116.4% |
| YTD | +388.2% | +13.7% | +374.5% | +347.6% |
| 1Y | +467.0% | +67.4% | +399.6% | +343.9% |
| 3Y | +36.1% | -13.2% | +49.3% | +29.9% |
| 5Y | -68.0% | -39.5% | -28.5% | -67.3% |
| All | +674.0% | +72.0% | +602.1% | +449.0% |
Cumulative growth
Daily Returns
Daily percentage return beside BRKR.
Daily Out/Under-Performance
Portfolio return minus BRKR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BRKR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BRKR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling